Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study

OBJECTIVES: This is the first clinical trial of this type in Japan, designed to analyze two important aspects of Alzheimer’s disease (AD) management using medium-chain triglycerides. Axona was administered for 3 months (40 g of powder containing 20 g of caprylic triglycerides). We used an indurating...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Interv Aging
Asıl Yazarlar: Ohnuma, Tohru, Toda, Aiko, Kimoto, Ayako, Takebayashi, Yuto, Higashiyama, Ryoko, Tagata, Yuko, Ito, Masanobu, Ota, Tsuneyoshi, Shibata, Nobuto, Arai, Heii
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2016
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4712972/
https://ncbi.nlm.nih.gov/pubmed/26811674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S95362
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller